Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
8-KReport of unscheduled material events or corporate eventJun 25, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJun 24, 2002View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KJun 18, 2002View HTMLDownload DOCDownload PDF
PRER14AProxy soliciting materials. Revised preliminary materialJun 14, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 12, 2002View HTMLDownload DOCDownload PDF
PRER14AProxy soliciting materials. Revised preliminary materialMay 21, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 16, 2002View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionMay 15, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 7, 2002View HTMLDownload DOCDownload PDFDownload XLS
10-K/AAmendment to a previously filed 10-KApr 30, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-3Simplified registration formApr 25, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventApr 24, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventApr 16, 2002View HTMLDownload DOCDownload PDF
PREM14AA preliminary proxy statement relating to a merger or acquisitionApr 12, 2002View HTMLDownload DOCDownload PDFDownload XLS
S-8Securities offered to employees pursuant to employee benefit plansApr 2, 2002View HTMLDownload DOCDownload PDFDownload XLS
10-KAnnual report which provides a comprehensive overview of the company for the past yearApr 1, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 21, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 26, 2002View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 14, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventFeb 7, 2002View HTMLDownload DOCDownload PDF
8-K/AAmendment to a previously filed 8-KJan 15, 2002View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJan 15, 2002View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 7, 2002View HTMLDownload DOCDownload PDF
1-25      26-48

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information